Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Diseases of the Thyroid

Free Subscription Articles published in Clin Nucl Med Retrieve available abstracts of 85 articles: HTML format

Single Articles

November 2025
1. RAVADA SK, Parghane RV, Basu S
   Dichotomous Uptake Pattern on [18F]F-FDG and [68Ga]Ga-DOTA-FAPI-04 PET/CT in Lytic, Sclerotic and Marrow Metastatic Skeletal Lesions in Medullary Thyroid Carcinoma.
   Clin Nucl Med. 2025 Nov 3. doi: 10.1097/RLU.0000000000006206.
   PubMed     Abstract available
   
   
   October 2025
2. SABER TANHA A, Jafari Zarrin Ghabaei F, Raeisi N, Aryana K, et al
   FAPI-Based Theranostics in Medullary Thyroid Cancer: A Viable Alternative When Somatostatin Receptor-Based Theranostics Show Limited Efficacy-A Clinical Experience.
   Clin Nucl Med. 2025 Oct 30. doi: 10.1097/RLU.0000000000006127.
   PubMed     Abstract available
   
   
   
3. HUANG D, Ji Y, Jiang C, Zhang C, et al
   Extensive Intravenous Tumor Thrombus and Right Atrial Bland Thrombus From Poorly Differentiated Thyroid Cancer: 18F-FDG PET/CT Imaging Findings.
   Clin Nucl Med. 2025 Oct 29. doi: 10.1097/RLU.0000000000006154.
   PubMed     Abstract available
   
   
   September 2025
4. SINGAREDDY CTR, Bal C, Satapathy S, Chandekar KR, et al
   Radioiodine Plus Low-Dose Lenvatinib in Radioiodine-Sensitive High-Volume Metastatic Differentiated Thyroid Cancer: A Pilot Study.
   Clin Nucl Med. 2025 Sep 26. doi: 10.1097/RLU.0000000000006146.
   PubMed     Abstract available
   
   
   
5. AHMADI M, Sahafi P, Elahifard H, Bahonar M, et al
   Focal Radioiodine Uptake in the Lower Limb: A Benign Mimicker of Metastasis in High-risk Differentiated Thyroid Cancer.
   Clin Nucl Med. 2025 Sep 17. doi: 10.1097/RLU.0000000000006136.
   PubMed     Abstract available
   
   
   
6. NAZERANI-ZEMANN T, Gstettner C, Tsybrovskyy O, Stranger N, et al
   When Benign Is Not Simple: Suspicious Thyroid Scintigraphy Revealing PTEN Hamartoma Tumor Syndrome in a Pediatric Patient.
   Clin Nucl Med. 2025 Sep 10. doi: 10.1097/RLU.0000000000006090.
   PubMed     Abstract available
   
   
   August 2025
7. WANG G, Zhang Y, Li J, Lu C, et al
   Unusual 131I Uptake in Talus May Reveal Distant Papillary Thyroid Cancer Metastasis With Anaplastic Transformation.
   Clin Nucl Med. 2025 Aug 20. doi: 10.1097/RLU.0000000000006102.
   PubMed     Abstract available
   
   
   
8. SHU Q, Xiao Y, Han Y, Deng M, et al
   Unusual 131 I Uptake in the Right Sternocleidomastoid Muscle After Parathyroid Transplantation on 131 I Whole-Body Scintigraphy.
   Clin Nucl Med. 2025;50:804-805.
   PubMed     Abstract available
   
   
   July 2025
9. ZHOU Y, Chen H, Shu H, Qin C, et al
   68Ga-FAPI PET/MR for Active Thyroid Eye Disease Following Thyroidectomy: A Case Supporting Its Dual Role in Clinical Management.
   Clin Nucl Med. 2025 Jul 29. doi: 10.1097/RLU.0000000000006081.
   PubMed     Abstract available
   
   
   
10. LONG Y, Ge S, Xu X, Jiang K, et al
    6-Deoxy-6-[18F]Fluoro-L-Ascorbic Acid PET/CT in the Detection of Lymph Node Metastases for Postoperative Differentiated Thyroid Cancer Patients: Using Histopathology as Reference Standard.
    Clin Nucl Med. 2025 Jul 1. doi: 10.1097/RLU.0000000000006026.
    PubMed     Abstract available
    
    
    
11. BILGIN C, Belge Bilgin G, Dundar B, Kapplinger JD, et al
    I-131 Uptake in a Benign Diaphragmatic Mesothelial Cyst Mimicking Thyroid Cancer Metastasis on Post-therapy SPECT/CT.
    Clin Nucl Med. 2025 Jul 1. doi: 10.1097/RLU.0000000000005923.
    PubMed     Abstract available
    
    
    June 2025
12. BAGHERI S, Hajianfar G, Sabouri M, Gharibi O, et al
    Impact of Field-of-view Zooming and Segmentation Batches on Radiomics Features Reproducibility and Machine Learning Performance in Thyroid Scintigraphy.
    Clin Nucl Med. 2025 Jun 17. doi: 10.1097/RLU.0000000000005995.
    PubMed     Abstract available
    
    
    
13. WANG G, Han N, Wang C, Si Z, et al
    Unusual I-131 Accumulation in the Gallbladder and Intrahepatic Cholangiocarcinoma in a Patient With Papillary Thyroid Cancer.
    Clin Nucl Med. 2025 Jun 9. doi: 10.1097/RLU.0000000000006018.
    PubMed     Abstract available
    
    
    
14. HOU N, Dai H, Huang R, Su M, et al
    18F-DOPA Uptake by Stellate Ganglion on PET/CT Masquerading Medullary Thyroid Carcinoma Metastasis.
    Clin Nucl Med. 2025 Jun 9. doi: 10.1097/RLU.0000000000005760.
    PubMed     Abstract available
    
    
    
15. AGHAEE A, Soltani S, Soltani E, Sahafi P, et al
    Revolutionizing Thyroid Cancer Treatment: Restoring Radioiodine Avidity After PRRT-A Case Series.
    Clin Nucl Med. 2025 Jun 6. doi: 10.1097/RLU.0000000000005809.
    PubMed     Abstract available
    
    
    
16. GLANTSCHNIG L, Reitsam NG, Kleffel T, Lapa C, et al
    [18F]FDG PET/CT in Primary Angiosarcoma of the Thyroid.
    Clin Nucl Med. 2025 Jun 4. doi: 10.1097/RLU.0000000000006012.
    PubMed     Abstract available
    
    
    May 2025
17. RAVADA SK, Parghane RV, Malhotra G, Basu S, et al
    Atypical Presentation of Liver Metastasis in Medullary Thyroid Carcinoma: Variable Pattern and Interlesional Heterogeneity Observed on 18F-FDG, 68Ga-DOTATATE, and 68Ga-DOTA-FAPI-04 PET/CT.
    Clin Nucl Med. 2025 May 20. doi: 10.1097/RLU.0000000000005965.
    PubMed     Abstract available
    
    
    
18. KIM HI, Kim B, Hyeon J, Ko NG, et al
    Impact of Therapeutic Radioactive Iodine on the Recurrence of Papillary Thyroid Cancer With Extranodal Extension in Metastatic Lymph Nodes: A Propensity Score-matched Analysis.
    Clin Nucl Med. 2025 May 9. doi: 10.1097/RLU.0000000000005940.
    PubMed     Abstract available
    
    
    
19. RAEISI N, Saber Tanha A, Gozashti MH, Kiamanesh Z, et al
    177Lu-FAPI-2286 Therapy in a Patient With Radio-iodine Refractory Papillary Thyroid Carcinoma: A Favorable Clinical and Biochemical Response.
    Clin Nucl Med. 2025;50:e315-e316.
    PubMed     Abstract available
    
    
    
20. GHAHRAMAN M, Aryana K, Zakavi SR, Karamian F, et al
    Significant 99mTc-FAPI-46 Uptake in 2 Cases of TENIS Syndrome With Negative Tc-OCTREOTIDE Scan, a New Hope in Theranostic Applications.
    Clin Nucl Med. 2025;50:e290-e291.
    PubMed     Abstract available
    
    
    April 2025
21. SAMADI MH, Sahafi P, Ahmadi M, Khezri S, et al
    Autonomously Functioning Thyroid Nodule With 99mTc-PSMA Uptake in a Patient With Prostate Cancer.
    Clin Nucl Med. 2025 Apr 30. doi: 10.1097/RLU.0000000000005853.
    PubMed     Abstract available
    
    
    
22. RAEISI N, Saber Tanha A, Ataei Azimi S, Aryana K, et al
    Combination Therapy With 177Lu-FAPI-2286 and Tyrosine Kinase Inhibitor: A Novel Approach for Treating Metastatic Medullary Thyroid Carcinoma.
    Clin Nucl Med. 2025 Apr 17. doi: 10.1097/RLU.0000000000005723.
    PubMed     Abstract available
    
    
    March 2025
23. WANG Y, Zhang L, Qiao F, Zhang W, et al
    Thyroid Tuberculosis Depicted by 18F-FAPI PET/CT.
    Clin Nucl Med. 2025 Mar 18. doi: 10.1097/RLU.0000000000005799.
    PubMed     Abstract available
    
    
    
24. GHAHRAMAN M, Sahafi P, Samadi MH, Aryana K, et al
    Remarkable 99mTc-FAPI-46 Uptake in a Patient With Anaplastic Thyroid Carcinoma: A Promising Step in Theranostic Field.
    Clin Nucl Med. 2025 Mar 11. doi: 10.1097/RLU.0000000000005746.
    PubMed     Abstract available
    
    
    
25. RAEISI N, Saber Tanha A, Aryana K, Akbari Oryani M, et al
    99mTc-FAPI-46 Uptake in Simultaneous Occurrence of Benign Thyroid Nodule and Mixed-Mucinous-Invasive Ductal Breast Carcinoma.
    Clin Nucl Med. 2025 Mar 5. doi: 10.1097/RLU.0000000000005729.
    PubMed     Abstract available
    
    
    
26. JUWEID ME, Abdulrahman M, Albtoush O, Al-Qasem SF, et al
    Two Distinct Hyperactive Thyrothymic Remnants in a Patient With Graves' Disease.
    Clin Nucl Med. 2025 Mar 3. doi: 10.1097/RLU.0000000000005715.
    PubMed     Abstract available
    
    
    
27. LIN CY, Lin CL, Kao CH
    Risk of Infertility in Reproductive-Age Patients With Thyroid Cancer Receiving or Not Receiving 131I Treatment: A Nationwide Population-Based Cohort Study.
    Clin Nucl Med. 2025;50:201-207.
    PubMed     Abstract available
    
    
    February 2025
28. ISIK EG, Has Simsek D, Gul N, Erturk SM, et al
    Head-to-Head Comparison of 68Ga-FAPI-04 and 68Ga-DOTA-TATE PET/CT in Recurrent Medullary Thyroid Cancer.
    Clin Nucl Med. 2025;50:e80-e86.
    PubMed     Abstract available
    
    
    January 2025
29. RICHARD C, Al Ghuzlan A, Huchet V, Cockenpot V, et al
    Intranodular Thyroid Metastasis of a Large Cell Neuroendocrine Carcinoma of the Endometrium.
    Clin Nucl Med. 2025 Jan 9. doi: 10.1097/RLU.0000000000005665.
    PubMed     Abstract available
    
    
    
30. KIM M, Han YH, Jeong HJ, Jeong JS, et al
    Joker Sign After Drooling Radioactive Saliva.
    Clin Nucl Med. 2025;50:96-97.
    PubMed     Abstract available
    
    
    
31. TRAVAGLIO MORALES D, Kreissl MC, Fischer F, Heinzel A, et al
    Apparently Benign 131 I Adrenal Uptake.
    Clin Nucl Med. 2025;50:77-79.
    PubMed     Abstract available
    
    
    December 2024
32. RAEISI N, Saber Tanha A, Barashki S, Nateghi N, et al
    Application of 99mTc-FAPI-46 Imaging in a Patient With Medullary Thyroid Carcinoma: Navigating the Landscape of Novel Radiotracers.
    Clin Nucl Med. 2024 Dec 31. doi: 10.1097/RLU.0000000000005605.
    PubMed     Abstract available
    
    
    November 2024
33. GONDHANE AI, Parghane RV, Basu S
    Incidental Detection of Prostatic Lesion on 18F-FDG PET/CT and 68Ga-PSMA-11 PET/CT Leading to Diagnosis of Second Primary Prostatic Adenocarcinoma in a Patient of Differentiated Thyroid Cancer.
    Clin Nucl Med. 2024 Nov 27. doi: 10.1097/RLU.0000000000005607.
    PubMed     Abstract available
    
    
    
34. FENG Y, Lan X, Zhang X
    131I Accumulation Due to an Intrauterine Device in a Papillary Thyroid Carcinoma Patient.
    Clin Nucl Med. 2024 Nov 27. doi: 10.1097/RLU.0000000000005597.
    PubMed     Abstract available
    
    
    
35. KOSEK S, Kilsved E, Danfors T, Cunningham JL, et al
    Regional Metabolic Abnormalities in Autoimmune Encephalitis: A Meta-analysis of 498 Cases With Brain FDG PET.
    Clin Nucl Med. 2024 Nov 27. doi: 10.1097/RLU.0000000000005574.
    PubMed     Abstract available
    
    
    
36. ISIK EG, Has Simsek D, Gul N, Erturk SM, et al
    Head-to-Head Comparison of 68Ga-FAPI-04 and 68Ga-DOTA-TATE PET/CT in Recurrent Medullary Thyroid Cancer.
    Clin Nucl Med. 2024 Nov 19. doi: 10.1097/RLU.0000000000005558.
    PubMed     Abstract available
    
    
    
37. MOSTOWSKI R, de Pontville M, Bardet S, Ciappuccini R, et al
    False-Positive Radioiodine Uptake Related to Posttraumatic Scab Demonstrated by SPECT/CT in a Patient With Differentiated Thyroid Cancer.
    Clin Nucl Med. 2024 Nov 12. doi: 10.1097/RLU.0000000000005563.
    PubMed     Abstract available
    
    
    
38. SINGHAL T, Agrawal K, Mandal S, Parida GK, et al
    Cancer-Specific Integrin Imaging With 68Ga-Trivehexin: A Potential Imaging for Accurate Staging of Thyroid Malignancy.
    Clin Nucl Med. 2024 Nov 5. doi: 10.1097/RLU.0000000000005557.
    PubMed     Abstract available
    
    
    October 2024
39. PISANO G, Sassano S, Rossi ED, D'Amore A, et al
    A Challenging Case of Hyperfunctioning Submandibular Ectopic Thyroid Successfully Treated With 131I.
    Clin Nucl Med. 2024 Oct 4. doi: 10.1097/RLU.0000000000005477.
    PubMed     Abstract available
    
    
    
40. EDAMADAKA Y, Parghane RV, Basu S
    Variable Tracer Avidity and Interlesional Heterogeneity on 18F-FDG, 68Ga-DOTATATE, and 68Ga-DOTA-FAPi-04 PET/CT Imaging in a Single Individual Patient With Progressive Metastatic Medullary Thyroid Carcinoma.
    Clin Nucl Med. 2024 Oct 4. doi: 10.1097/RLU.0000000000005469.
    PubMed     Abstract available
    
    
    
41. AYDINBELGE-DIZDAR N, Cinar A, Ozmen O, Senlik SD, et al
    Intratracheal Ectopic Thyroid Tissue Mimicking a Subglottic Mass in a Patient With Thyroid Follicular Carcinoma on SPECT/CT.
    Clin Nucl Med. 2024 Oct 2. doi: 10.1097/RLU.0000000000005468.
    PubMed     Abstract available
    
    
    September 2024
42. ALMEIDA LS, Santos A, Assumpcao L, Costa TO, et al
    68 Ga-DOTATATE PET/CT Versus 18 F-FDG PET/CT in TENIS Syndrome: A Head-to-Head Comparison With Elevated and Suppressed TSH Levels in Papillary Thyroid Carcinoma-A Pilot Study.
    Clin Nucl Med. 2024 Sep 12. doi: 10.1097/RLU.0000000000005366.
    PubMed     Abstract available
    
    
    August 2024
43. REDDY M, Ravina M, Goyal H, Kumar A, et al
    Nivolumab and Cabozantinib Immunotherapy Induced Thyroid Dysfunction Detected on 18F-FDG PET/CT in Renal Cell Carcinoma.
    Clin Nucl Med. 2024 Aug 28. doi: 10.1097/RLU.0000000000005407.
    PubMed     Abstract available
    
    
    
44. LIU W, Yang X, Gong W, Wang J, et al
    Elevated 131I Activity in Adrenal Cyst in a Patient With Thyroid Cancer.
    Clin Nucl Med. 2024 Aug 28. doi: 10.1097/RLU.0000000000005405.
    PubMed     Abstract available
    
    
    
45. VIERING O, Rinscheid A, Holzleitner N, Dierks A, et al
    Biodistribution and Radiation Dosimetry for 68Ga-DOTA-CCK-66, a Novel CCK2R-Targeting Compound for Imaging of Medullary Thyroid Cancer.
    Clin Nucl Med. 2024 Aug 2. doi: 10.1097/RLU.0000000000005355.
    PubMed     Abstract available
    
    
    
46. DENIZMEN D, Salmaslioglu A, Bakkaloglu DV, Simsek DH, et al
    Detecting Amyloid Goiter With 99mTc-PYP SPECT/CT in the Setting of Ankylosing Spondylitis: An Uncommon Involvement of AA Amyloidosis.
    Clin Nucl Med. 2024;49:e399-e400.
    PubMed     Abstract available
    
    
    
47. NG CWQ, Cheng LTJ, Chua WM, Tang CYL, et al
    131 I Uptake in a Left Cerebral Infarct on Posttherapy Whole-Body Scan.
    Clin Nucl Med. 2024;49:e415-e416.
    PubMed     Abstract available
    
    
    June 2024
48. ABDLKADIR AS, Almasri N, Estrada E, Fani Bozkurt M, et al
    18F-FDG PET/CT Unveils Coexistent Myelomatous Hepatosplenic and Thyroid Cartilage Involvement: A Rare Presentation in Multiple Myeloma.
    Clin Nucl Med. 2024 Jun 25. doi: 10.1097/RLU.0000000000005326.
    PubMed     Abstract available
    
    
    
49. HU S, Lan X, Cao W, Gao Z, et al
    Unusual Achalasia Presentation Detected on 131I SPECT/CT in a Papillary Thyroid Carcinoma Patient.
    Clin Nucl Med. 2024 Jun 20. doi: 10.1097/RLU.0000000000005337.
    PubMed     Abstract available
    
    
    
50. COSKUN M, Aydos U, Akdemir UO, Yalcin MM, et al
    PSMA-Avid Liver Metastasis in a Case of Prostate Carcinoma and Poorly Differentiated Thyroid Carcinoma.
    Clin Nucl Med. 2024 Jun 3. doi: 10.1097/RLU.0000000000005299.
    PubMed     Abstract available
    
    
    
51. CHEN Y, Zang J, Wu Z, Miao W, et al
    68Ga-FAPI-RGD PET/CT Detected Skull Metastasis Better Than 18F-FDG in a Patient With Radioiodine-Refractory Differentiated Thyroid Cancer.
    Clin Nucl Med. 2024 Jun 3. doi: 10.1097/RLU.0000000000005301.
    PubMed     Abstract available
    
    
    
52. KIM K, Hong CM, Ha M, Choi M, et al
    Efficacy of Empirical 131I Radioiodine Therapy in Well-Differentiated Thyroid Carcinoma Patients With Thyroglobulin-Elevated Negative Iodine Scintigraphy Syndrome: A Systematic Review and Meta-analysis.
    Clin Nucl Med. 2024 Jun 3. doi: 10.1097/RLU.0000000000005250.
    PubMed     Abstract available
    
    
    
53. SINGH P, Agrawal K, Patel RK, Patro PSS, et al
    Radioiodine Uptake at Suture Site Granuloma Mimicking Neck Node Metastasis on 131 I Whole-Body Iodine Scintigraphy.
    Clin Nucl Med. 2024;49:e301-e303.
    PubMed     Abstract available
    
    
    
54. GUREZ C, Ergul N
    Does Radioactive Iodine Treatment Damage the Lacrimal System?
    Clin Nucl Med. 2024;49:513-515.
    PubMed     Abstract available
    
    
    May 2024
55. CHUN IK, Lee S
    Papillary Thyroid Cancer, Small Cell Lung Cancer, and Parathyroid Adenoma Synchronously Visualized on 99mTc-MIBI SPECT/CT in a Patient With Hyperparathyroidism: Comparison With 18F-FDG PET/CT.
    Clin Nucl Med. 2024 May 23. doi: 10.1097/RLU.0000000000005267.
    PubMed     Abstract available
    
    
    
56. PARGHANE RV, Basu S
    Triple Tumors (Neuroendocrine Tumor, Schwannoma, and Papillary Thyroid Carcinoma) With Brain Lesions in a Single Patient Demonstrating Avidity on 68Ga-DOTATATE PET/CT and Their Characterization With FDG-PET/CT and Brain MRI.
    Clin Nucl Med. 2024 May 23. doi: 10.1097/RLU.0000000000005273.
    PubMed     Abstract available
    
    
    
57. NAZAR A, Kalshetty A, Basu S
    Incidental Detection of Second Primary Thyroid Malignancy in Patients of Metastatic Castration-Resistant Prostate Carcinoma: Documentation on 68Ga-PSMA-11 and 64CuCl2 PET/CT.
    Clin Nucl Med. 2024 May 15. doi: 10.1097/RLU.0000000000005287.
    PubMed     Abstract available
    
    
    
58. FOPPIANI L, Morbini P, Catrambone U, Fiz F, et al
    18F-FDG PET/CT in Cystic Papillary Thyroid Carcinoma.
    Clin Nucl Med. 2024 May 15. doi: 10.1097/RLU.0000000000005256.
    PubMed     Abstract available
    
    
    
59. MAKAREWICZ J, Rudzki J
    Beard Contamination With 131I Diagnosed by SPECT/CT in a Patient With Differentiated Thyroid Cancer.
    Clin Nucl Med. 2024 May 15. doi: 10.1097/RLU.0000000000005282.
    PubMed     Abstract available
    
    
    
60. HAIDAR MB, Abou Zeid FA, Meguerian ZZ, Al-Ibraheem AN, et al
    False-Negative 68Ga-FAPI PET/CT in Pediatric Thyroid Medullary Carcinoma Seen With 68Ga-DOTATOC PET/CT and 18F-FDG PET/CT.
    Clin Nucl Med. 2024 May 8. doi: 10.1097/RLU.0000000000005259.
    PubMed     Abstract available
    
    
    
61. KUMAR SA, Mittal BR, Kumar S, Singh H, et al
    FDG PET/CT in the Diagnosis and After Sunitinib Follow-up of Synchronous Base of Tongue and Thyroid Metastases From Renal Cell Carcinoma.
    Clin Nucl Med. 2024;49:e208-e210.
    PubMed     Abstract available
    
    
    
62. AK SIVRIKOZ I, Deveci H, Yildirim N
    A Rare False-Positive Whole-Body Scan in a Patient With Differentiated Thyroid Cancer: Unilateral Conjunctival Concretions.
    Clin Nucl Med. 2024;49:451-453.
    PubMed     Abstract available
    
    
    
63. WANG R, Cai H, Liu C, Lv Z, et al
    Two Cases of Synchronous Hodgkin Lymphoma and Papillary Thyroid Carcinoma in 18F-FDG PET/CT.
    Clin Nucl Med. 2024 May 1. doi: 10.1097/RLU.0000000000005261.
    PubMed     Abstract available
    
    
    April 2024
64. MOROTO D, Torquato-Vieira ICO, Fiorin LB, Camacho CP, et al
    Long-Term Follow-up of Patients With Autonomous Thyroid Nodules Treated With Radioiodine.
    Clin Nucl Med. 2024 Apr 12. doi: 10.1097/RLU.0000000000005189.
    PubMed     Abstract available
    
    
    March 2024
65. KAMARULZAMAN K, Mohd Rohani MF, Mat Nawi N, Amir Hassan SZ, et al
    Concurrent Benign Iodine-Avid Thymic and Liver Cysts Mimicking Metastatic Disease on 131I Whole-Body Scintigraphy.
    Clin Nucl Med. 2024;49:250-252.
    PubMed     Abstract available
    
    
    February 2024
66. VERMA P, Malhotra G, Rao RD, Sonavane S, et al
    Rare Presentations of Differentiated Thyroid Cancer Exposing Dr Jekyll and Mr Hyde Nature of an Otherwise Indolent Disease: Case Series.
    Clin Nucl Med. 2024 Feb 27. doi: 10.1097/RLU.0000000000005138.
    PubMed     Abstract available
    
    
    
67. YANG J, Pan Z, Su X
    Unusual 131I Uptake Caused by Paronychia in a Patient With Papillary Thyroid Cancer.
    Clin Nucl Med. 2024 Feb 23. doi: 10.1097/RLU.0000000000005134.
    PubMed     Abstract available
    
    
    
68. EICHHORN J, Nelson N, Raichandani S, Sesler A, et al
    Prostate-Specific Membrane Antigen PET/CT Detection of Prostate Cancer Metastasis to Thyroid and Cricoid Cartilages.
    Clin Nucl Med. 2024 Feb 23. doi: 10.1097/RLU.0000000000005111.
    PubMed     Abstract available
    
    
    
69. LATGE A, Krim M, Vija L, Ysebaert L, et al
    Diffuse Bone Uptake of 131I and Effect on Blood Counts in a Patient With Papillary Thyroid Carcinoma and Chronic Lymphocytic Leukemia.
    Clin Nucl Med. 2024 Feb 12. doi: 10.1097/RLU.0000000000005119.
    PubMed     Abstract available
    
    
    
70. LIANG Z, Li W
    Uptake of 99mTc-DTPA in Bone Metastases From Follicular Thyroid Carcinoma.
    Clin Nucl Med. 2024 Feb 7. doi: 10.1097/RLU.0000000000005100.
    PubMed     Abstract available
    
    
    
71. BABACAN GB, Acar Tayyar MN, Sahin MC, Sengiz Erhan S, et al
    Unusual Presence of Synchronous Primary Ovarian and Thyroid Extranodal Non-Hodgkin Lymphoma Without Lymph Node Involvement.
    Clin Nucl Med. 2024 Feb 2. doi: 10.1097/RLU.0000000000005108.
    PubMed     Abstract available
    
    
    January 2024
72. SHI X, Lan W, Bin J
    FAPI PET Missed Widespread Bone Marrow Metastases From Follicular Thyroid Cancer That Were Detected by FDG PET.
    Clin Nucl Med. 2024 Jan 24. doi: 10.1097/RLU.0000000000005031.
    PubMed     Abstract available
    
    
    
73. PARK S, Bang JI, Kim K, Seo Y, et al
    Comparison of Recombinant Human Thyroid-Stimulating Hormone and Thyroid Hormone Withdrawal for 131I Therapy in Patients With Intermediate- to High-Risk Thyroid Cancer: A Systematic Review and Meta-analysis.
    Clin Nucl Med. 2024 Jan 19. doi: 10.1097/RLU.0000000000005022.
    PubMed     Abstract available
    
    
    December 2023
74. NAZERANI-ZEMANN T, Pernthaler B, Abete L, Wienerroither VF, et al
    A Rare Case of Thyroid Sarcoidosis.
    Clin Nucl Med. 2023 Dec 18. doi: 10.1097/RLU.0000000000005008.
    PubMed     Abstract available
    
    
    
75. CHONG A, Seo Y, Bang JI, Park S, et al
    Clinical Implications of Adding SPECT/CT to Radioiodine Whole-Body Scan in Patients With Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
    Clin Nucl Med. 2023 Dec 1. doi: 10.1097/RLU.0000000000004953.
    PubMed     Abstract available
    
    
    October 2023
76. YANG J, Zhou P, Su X
    False-Positive 131I Uptake After Posttraumatic Scab in a Patient With Papillary Thyroid Carcinoma.
    Clin Nucl Med. 2023 Oct 6. doi: 10.1097/RLU.0000000000004895.
    PubMed     Abstract available
    
    
    September 2023
77. ROSHANRAVAN V, Sadeghi R, Zakavi SR, Norouzbeigi N, et al
    Unilateral Chronic Parotitis With 68Ga-DOTA-FAPI-04 PET/CT and 18F-FDG PET/CT Imaging in a Case of a Patient With Papillary Thyroid Carcinoma.
    Clin Nucl Med. 2023 Sep 25. doi: 10.1097/RLU.0000000000004884.
    PubMed     Abstract available
    
    
    
78. LEE H, States LJ
    Langerhans Cell Histiocytosis With Thyroid Involvement on 18F-FDG PET/MR.
    Clin Nucl Med. 2023 Sep 21. doi: 10.1097/RLU.0000000000004822.
    PubMed     Abstract available
    
    
    
79. ZHONG P, Yang J, Wang Y, Wei L, et al
    Thyroid Accumulation of 99mTc-DTPA in Graves Disease.
    Clin Nucl Med. 2023 Sep 7. doi: 10.1097/RLU.0000000000004858.
    PubMed     Abstract available
    
    
    
80. SHI Y, Tang L, Fei M, Liu J, et al
    68Ga-FAPI-Avid Submental Ectopic Papillary Thyroid Carcinoma and Lateral Neck Lymphadenopathy With Low 18F-FDG Uptake.
    Clin Nucl Med. 2023 Sep 7. doi: 10.1097/RLU.0000000000004810.
    PubMed     Abstract available
    
    
    June 2023
81. XU Y, Shi L, Wu J, Li H, et al
    No Association of Preablation Thyroglobulin Antibody Positivity and Outcome in Pediatric Patients With Papillary Thyroid Carcinoma.
    Clin Nucl Med. 2023 Jun 29. doi: 10.1097/RLU.0000000000004758.
    PubMed     Abstract available
    
    
    
82. TAN X, Wang H, Deng Y, He L, et al
    False-Positive Radioactive Iodine Uptake Caused by Cervical Myofascitis in a Patient With Differentiated Thyroid Carcinoma.
    Clin Nucl Med. 2023;48:512-514.
    PubMed     Abstract available
    
    
    May 2023
83. MAKAREWICZ M, Skierkowski W, Makarewicz J
    Orbital Radioiodine Uptake in Epithelial Conjunctival Inclusion Cyst on Scintigraphy in a Patient With Differentiated Thyroid Cancer.
    Clin Nucl Med. 2023 May 23. doi: 10.1097/RLU.0000000000004707.
    PubMed     Abstract available
    
    
    March 2023
84. KO WS, Kim SJ
    Prediction of Malignant Thyroid Nodules Using 18F-FDG PET/CT-Based Radiomics Features in Thyroid Incidentalomas.
    Clin Nucl Med. 2023 Mar 30. doi: 10.1097/RLU.0000000000004637.
    PubMed     Abstract available
    
    
    October 2021
85. RAHBAR K, Ahmadzadehfar H
    Re: Medical Event: Accidental Oral Administration of 177Lu-PSMA to a Patient With Hyperthyroidism.
    Clin Nucl Med. 2021;46:856.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge.